Sangamo BioSciences | SGMO - 무역 채권자





무역 채권자 변화 날짜
Alaunos Therapeutics USD 843K 34K 2025-09
Alnylam Pharmaceuticals USD 115.72M 1.87M 2025-12
Alterity Therapeutics Limited AUD 1.27M 1.81M 2024-12
Amgen USD 20.89B 1.25B 2025-12
Bayer EUR 7.08B 700M 2025-12
BioCryst Pharmaceuticals USD 15.83M 10.26M 2025-12
Biogen USD 432M 18.9M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Cipla INR 30.35B 1.98B 2025-09
Clal Biotechnology ILS 21.05M 1.62M 2021-12
Compugen USD 2.35M 6.77M 2025-12
CSL USD 3.17B 290M 2025-12
Gilead Sciences USD 808M 226M 2025-09
GlaxoSmithKline GBP 15.38B 294M 2025-12
Grifols EUR 987.75M 47.87M 2025-12
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
J&J USD 11.99B 2.37B 2025-12
Karyopharm Therapeutics USD 5.39M 2.8M 2025-09
Merck USD 4.15B 102M 2025-09
Novartis USD 4.46B 99M 2025-12
Omeros USD 8.84M 4.42M 2025-06
Pfizer USD 5.02B 142M 2025-09
Roche Holding CHF 5.78B 1.27B 2025-12
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sanofi EUR 22.93B 927M 2025-12
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
Tectonic Therapeutic USD 1.09M 392K 2025-12
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
Vertex Pharmaceuticals USD 3.43B 600.9M 2025-12